Tonix Pharmaceuticals Holding Corp.
TNXP
$13.38
$0.141.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.91M | -32.01M | -28.27M | -16.83M | -22.11M |
| Total Depreciation and Amortization | 488.00K | 461.00K | 483.00K | 493.00K | 496.00K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 0.00 | 65.00K | 200.00K |
| Total Other Non-Cash Items | 1.14M | 2.15M | 5.54M | 2.97M | 366.00K |
| Change in Net Operating Assets | 5.63M | 616.00K | 7.42M | -3.28M | 6.42M |
| Cash from Operations | -39.65M | -28.78M | -14.83M | -16.58M | -14.63M |
| Capital Expenditure | -1.87M | -962.00K | -527.00K | -6.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 853.00K | 0.00 | -2.01M | -- | -- |
| Cash from Investing | -1.02M | -962.00K | -2.54M | -6.00K | -3.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -9.65M | -705.00K |
| Issuance of Common Stock | 69.95M | 97.85M | 14.38M | 64.50M | 89.16M |
| Repurchase of Common Stock | -7.81M | 0.00 | -2.90M | -3.05M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.00M | -2.99M | -487.00K | -2.27M | -3.30M |
| Cash from Financing | 59.14M | 94.86M | 10.99M | 49.53M | 85.15M |
| Foreign Exchange rate Adjustments | -14.00K | -4.00K | -4.00K | -9.00K | 24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.46M | 65.11M | -6.38M | 32.94M | 70.55M |